Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weon-Kyoo You

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Cancer|July 11, 2019
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancerYoujin Kim, Sun-Ju Byeon, Joonyoung Hur, et al.
BMB Reports|June 26, 2020
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancerDa-Hyun Kim, Seul Lee, Hyeok Gu Kang, et al.
Biochemical and Biophysical Research Communications|March 28, 2006
Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAMMi-Ran Youn, Mee-Hee Park, Chang-Ki Choi, et al.
Molecular Cancer Therapeutics|April 20, 2026
ABL209 (NEOK002) : Designing an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic windowBora Lee, Hyeon Ji Park, Byeong Min Yoo, et al.
Applied Microbiology and Biotechnology|March 22, 2023
Enhanced cell growth, production, and mAb quality produced in Chinese hamster ovary-K1 cells by supplementing polyamine in the mediaDa Eun Kang, Yeong Bin An, Yeunju Kim, et al.
Cell Reports Methods|December 1, 2022
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrierJung-Won Shin, Sungwon An, Dongin Kim, et al.
NPJ Parkinson'S Disease|August 22, 2025
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathiesSungwon An, John J McInnis, Dongin Kim, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Cancer|July 11, 2019
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancerYoujin Kim, Sun-Ju Byeon, Joonyoung Hur, et al.
BMB Reports|June 26, 2020
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancerDa-Hyun Kim, Seul Lee, Hyeok Gu Kang, et al.
Biochemical and Biophysical Research Communications|March 28, 2006
Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAMMi-Ran Youn, Mee-Hee Park, Chang-Ki Choi, et al.
Molecular Cancer Therapeutics|April 20, 2026
ABL209 (NEOK002) : Designing an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic windowBora Lee, Hyeon Ji Park, Byeong Min Yoo, et al.
Applied Microbiology and Biotechnology|March 22, 2023
Enhanced cell growth, production, and mAb quality produced in Chinese hamster ovary-K1 cells by supplementing polyamine in the mediaDa Eun Kang, Yeong Bin An, Yeunju Kim, et al.
Cell Reports Methods|December 1, 2022
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrierJung-Won Shin, Sungwon An, Dongin Kim, et al.
NPJ Parkinson'S Disease|August 22, 2025
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathiesSungwon An, John J McInnis, Dongin Kim, et al.
Pageof 4